Please see below for a selection of interesting articles on pediatric CML in peer-reviewed journals. Latest publications include:

• Discontinuation of imatinib in a child with chronic myeloid leukemia
  (Jeyaram P et al. J Pediatr Hematol Oncol, January 2020)
• Aquired neuro-secretory defect in growth hormone secretion due to imatinib mesylate and the efficacy of growth hormone therapy in children with chronic myeloid leukemia
  (Walia R et al. Pediatr Hematol Oncol, November 2019) (epub ahead of print)
• Bleeding signs due to acquired von Willebrand syndrome at diagnosis of chronic myeloid leukemia in children
  (Knöfler R et al. Br J Haematol, October 2019) (epub ahead of print)
• Discontinuation of tyrosine kinase inhibitor in children with chronic myeloid leukemia (JPLSG STKI-14 study)
  (Shima H et al. Blood, November 2019)

Search here for more publications on pediatric CML